Minimum data elements for research reports on CFS

Chronic fatigue syndrome (CFS) is a debilitating condition that has received increasing attention from researchers in the past decade. However, it has become difficult to compare data collected in different laboratories due to the variability in basic information regarding descriptions of sampling methods, patient characteristics, and clinical assessments. The issue of variability in CFS research was recently highlighted at the NIH's 2011 State of the Knowledge of CFS meeting prompting researchers to consider the critical information that should be included in CFS research reports. To address this problem, we present our consensus on the minimum data elements that should be included in all CFS research reports, along with additional elements that are currently being evaluated in specific research studies that show promise as important patient descriptors for subgrouping of CFS. These recommendations are intended to improve the consistency of reported methods and the interpretability of reported results. Adherence to minimum standards and increased reporting consistency will allow for better comparisons among published CFS articles, provide guidance for future research and foster the generation of knowledge that can directly benefit the patient.

[1]  Molly Brown,et al.  Contrasting Case Definitions for Chronic Fatigue Syndrome, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Myalgic Encephalomyelitis , 2012, Evaluation & the health professions.

[2]  The validity of an empirical delineation of heterogeneity in chronic unexplained fatigue. , 2006, Pharmacogenomics.

[3]  Rosane Nisenbaum,et al.  Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution , 2003, BMC health services research.

[4]  D. Buchwald,et al.  Evidence for overlap between urological and nonurological unexplained clinical conditions. , 2009, The Journal of urology.

[5]  L. Jason,et al.  The Development of a Revised Canadian Myalgic Encephalomyelitis Chronic Fatigue Syndrome Case Definition , 2010 .

[6]  Susan K. Johnson Understanding Chronic Fatigue Syndrome: An Empirical Guide to Assessment and Treatment , 1999, Journal of health psychology.

[7]  J. Furst,et al.  Data mining: comparing the empiric CFS to the Canadian ME/CFS case definition. , 2012, Journal of clinical psychology.

[8]  M. Litt,et al.  Momentary pain and coping in temporomandibular disorder pain: Exploring mechanisms of cognitive behavioral treatment for chronic pain , 2009, PAIN®.

[9]  M. Bergner,et al.  The Sickness Impact Profile: Development and Final Revision of a Health Status Measure , 1981, Medical care.

[10]  M. Houghton The long and winding road leading to the identification of the hepatitis C virus. , 2009, Journal of hepatology.

[11]  J. VanNess,et al.  Subclassifying chronic fatigue syndrome through exercise testing. , 2003, Medicine and science in sports and exercise.

[12]  L. Carmel,et al.  Gene expression profile of empirically delineated classes of unexplained chronic fatigue. , 2006, Pharmacogenomics.

[13]  B. Ainsworth,et al.  International physical activity questionnaire: 12-country reliability and validity. , 2003, Medicine and science in sports and exercise.

[14]  N. Speight,et al.  Myalgic encephalomyelitis. , 1985, The New Zealand medical journal.

[15]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[16]  L. Jason,et al.  Measuring substantial reductions in functioning in patients with chronic fatigue syndrome , 2011, Disability and rehabilitation.

[17]  C. Lavie,et al.  Understanding the basics of cardiopulmonary exercise testing. , 2006, Mayo Clinic proceedings.

[18]  R. Hargreaves,et al.  Clinical biomarkers in drug discovery and development , 2003, Nature Reviews Drug Discovery.

[19]  Replication of an empirical approach to delineate the heterogeneity of chronic unexplained fatigue , 2009, Population health metrics.

[20]  A. Børresen-Dale,et al.  The Genetics and Epigenetics of Fatigue , 2010, PM & R : the journal of injury, function, and rehabilitation.

[21]  Ian Hickie,et al.  The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study , 1994, Annals of Internal Medicine.

[22]  James F. Jones,et al.  Chronic Fatigue Syndrome – A clinically empirical approach to its definition and study , 2005, BMC medicine.

[23]  L. Jason,et al.  Myalgic Encephalomyelitis Case Definitions , 2011 .

[24]  Gordon Broderick,et al.  Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood , 2008, Behavioral and Brain Functions.

[25]  N. Klimas,et al.  Chronic fatigue syndrome: Inflammation, immune function, and neuroendocrine interactions , 2007, Current rheumatology reports.

[26]  S. Carr,et al.  A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease , 2011, Nature Biotechnology.

[27]  Ware J.E.Jr.,et al.  THE MOS 36- ITEM SHORT FORM HEALTH SURVEY (SF- 36) CONCEPTUAL FRAMEWORK AND ITEM SELECTION , 1992 .

[28]  Jin-Mann S. Lin,et al.  The economic impact of chronic fatigue syndrome in Georgia: direct and indirect costs , 2011 .

[29]  H. Roschel,et al.  Cardiac autonomic impairment and chronotropic incompetence in fibromyalgia , 2011, Arthritis research & therapy.

[30]  L. Jason,et al.  The Economic impact of ME/CFS: Individual and societal costs , 2008, Dynamic medicine : DM.

[31]  L. Gerber,et al.  Scoring methods and application of the activity record (ACTRE) for patients with musculoskeletal disorders. , 1992, Arthritis care and research : the official journal of the Arthritis Health Professions Association.

[32]  D. Buchwald,et al.  Evidence for overlap between urological and nonurological unexplained clinical conditions. , 2009, The Journal of urology.

[33]  Ross Arena,et al.  Clinician's Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. , 2010, Circulation.

[34]  B. McEwen,et al.  Stress and the individual. Mechanisms leading to disease. , 1993, Archives of internal medicine.

[35]  Richard D. Smith,et al.  Distinct Cerebrospinal Fluid Proteomes Differentiate Post-Treatment Lyme Disease from Chronic Fatigue Syndrome , 2011, PloS one.

[36]  Nigel W. Hardy,et al.  Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project , 2008, Nature Biotechnology.

[37]  J. Larson The MOS 36-Item Short form Health Survey , 1997, Evaluation & the health professions.

[38]  U. Vollmer-Conna,et al.  An empirical delineation of the heterogeneity of chronic unexplained fatigue in women. , 2006, Pharmacogenomics.

[39]  P. Flor-Henry,et al.  Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols , 2003 .

[40]  L. Cantor Handbook of Chronic Fatigue Syndrome , 2005 .

[41]  Paul Kellam,et al.  Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis. , 2008, The Journal of infectious diseases.

[42]  A. Light,et al.  Moderate exercise increases expression for sensory, adrenergic, and immune genes in chronic fatigue syndrome patients but not in normal subjects. , 2009, The journal of pain : official journal of the American Pain Society.

[43]  D. Moher,et al.  CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials , 2010, Journal of pharmacology & pharmacotherapeutics.

[44]  F Friedberg,et al.  Symptom patterns in long-duration chronic fatigue syndrome. , 2000, Journal of psychosomatic research.

[45]  I. Hickie,et al.  Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study , 2006, BMJ : British Medical Journal.

[46]  James F. Jones,et al.  Psychometric properties of the CDC Symptom Inventory for assessment of Chronic Fatigue Syndrome , 2005, Population health metrics.